Aflibercept
Aflibercept
Des-432-lysine-[human vascular endothelial growth factor receptor 1-(103-204)-peptide (containing lg-like C2-type 2 domain) fusion protein with human vascular endothelial growth factor receptor 2-(206-308)-peptide
Stoffgruppe
Ophthalmikum (antineovaskuläres Mittel), antineoplastisches Mittel (VEGF-Inhibitor)
Halbwertszeit
ca. 144 h (i.v. Anw.)
Hämoperfusion
nein
Hämodialyse
nein
Präparate